Regenevita Health

Regenevita Health is a regenerative medicine company and clinical provider specializing in autologous cell therapies and biocellular treatments. The company focuses on the use of cellular Stromal Vascular Fraction (cSVF), high-density platelet-rich plasma (HD-PRP), and adipose-derived stem cells to treat a variety of conditions including orthopedic injuries, neurodevelopmental disorders like Autism, and autoimmune diseases. Regenevita also develops and markets a line of longevity and cellular health supplements under the Regenavita brand, targeting mitochondrial function and healthy aging. Their business model integrates clinical practice, physician training, and research into advanced regenerative protocols. The company is led by Dr. Robert W. Alexander and maintains a strong focus on evidence-based regenerative surgery and aesthetic medicine.